Grantham W G, Fitch F W
J Immunol. 1975 Jan;114(1 Pt 2):394-8.
Spleen cells from mice immunized with a low dose of SRBC produce a greater secondary response to subsequent antigenic challenge in vivo than spleen cells from mice initially immunized with a larger dose. However, when the spleen cells are removed from the mice and given a secondary challange in tissue culture, a greater response is produced by cells from animals primed with the larger dose. Serum from the mice receiving the high dose of antigen contains low, but significant levels of specific antibody, and can inhibit further antibody production by lymphoid cells in vivo and in vitro. The characteristics of this suppression are similar to those known for passively administered specific antibody. Thus, antibody produced as a result of primary immunization may act through an inhibitory feedback mechanism in specifically limiting the magnitude of the secondary response to subsequent antigenic challenge in the normal animal
用低剂量绵羊红细胞免疫的小鼠的脾细胞,对后续体内抗原攻击产生的二次反应比最初用高剂量免疫的小鼠的脾细胞更强。然而,当从小鼠体内取出脾细胞并在组织培养中进行二次攻击时,最初用高剂量免疫的动物的细胞产生的反应更强。接受高剂量抗原的小鼠的血清含有低但显著水平的特异性抗体,并且可以在体内和体外抑制淋巴细胞进一步产生抗体。这种抑制的特征与被动给予特异性抗体的已知特征相似。因此,初次免疫产生的抗体可能通过抑制性反馈机制,特异性地限制正常动物对后续抗原攻击的二次反应的强度。